31 Mar 2024
Assets22.68
Total Income27.66
EBITDA5.26
Profit After Tax2.93
NET Worth15.06
Reserves and Surplus9.95
Total Borrowing2.86
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Revenue36.93₹ Cr · -36.9% vs prior year
EBITDA6.51₹ Cr · -28.4% vs prior year
PAT6.06₹ Cr · -29.6% vs prior year
Assets45.57₹ Cr · +14.0% vs prior year
Net Worth36.47₹ Cr · +19.9% vs prior year
Borrowing4.81₹ Cr · -4.8% vs prior year
3-year financial trendRevenue / EBITDA / PAT
₹ crore31 Mar 2025
Assets39.98
Total Income58.54
EBITDA9.09
Profit After Tax8.61
NET Worth30.42
Reserves and Surplus23.98
Total Borrowing5.05
31 Oct 2025
Assets45.57
Total Income36.93
EBITDA6.51
Profit After Tax6.06
NET Worth36.47
Reserves and Surplus30.04
Total Borrowing4.81
IPO UPDATE ALERTS
Register for IPO Updates →Track Speciality Medicines without missing an update
Register for subscription, GMP, allotment and listing notifications.